[PDF] mdpi.com

Exploring the role of immune system and inflammatory cytokines in SARS-CoV-2 induced lung disease: a narrative review

C Tirelli, M De Amici, C Albrici, S Mira, G Nalesso, B Re… - Biology, 2023 - mdpi.com
Simple Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the pandemic coronavirus disease-2019 (COVID-19), which can lead to …
被引用次数：18 相关文章 所有 12 个版本
[PDF] frontiersin.org

Overview: systemic inflammatory response derived from lung injury caused by SARS-CoV-2 infection explains severe outcomes in COVID-19

RB Polidoro, RS Hagan, R de Santis Santiago… - Frontiers in …, 2020 - frontiersin.org
Most SARS-CoV2 infections will not develop into severe COVID-19. However, in some
patients, lung infection leads to the activation of alveolar macrophages and lung epithelial …
被引用次数：195 相关文章 所有 13 个版本
[PDF] mdpi.com

Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine …

AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh… - Pathogens, 2021 - mdpi.com
The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …
被引用次数：72 相关文章 所有 20 个版本
[HTML] nih.gov

Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview

LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
被引用次数：78 相关文章 所有 6 个版本
[PDF] sagepub.comFull View

Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications

C Pelaia, C Tinello, A Vatrella… - Therapeutic …, 2020 - journals.sagepub.com
The lung is a key target of the cytokine storm that can be triggered by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the widespread clinical …
被引用次数：134 相关文章 所有 10 个版本
[HTML] nih.gov

Immunobiology and immunotherapy of COVID‐19: A clinically updated overview

A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
被引用次数：91 相关文章 所有 5 个版本
[HTML] nih.gov

The immune system and COVID-19: Friend or foe?

F Yazdanpanah, MR Hamblin, N Rezaei - Life sciences, 2020 - Elsevier
Abstract Aim Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection
caused by SARS-CoV-2, which has been became a global public health challenge. The …
被引用次数：304 相关文章 所有 10 个版本
[HTML] nih.gov

[HTML][HTML] Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy

Y Shimizu - World journal of clinical cases, 2020 - ncbi.nlm.nih.gov
Although 80% of individuals infected with the severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2) recover without antiviral treatments, the other 20% progress to …
被引用次数：17 相关文章 所有 11 个版本
[PDF] springer.com

A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)

R Lotfi, RN Kalmarzi, SA Roghani - Immunologic research, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by a
newly identified coronavirus called the severe acute respiratory syndrome-coronavirus 2 …
被引用次数：38 相关文章 所有 6 个版本

Early insights into immune responses during COVID-19

AL St John, APS Rathore - The Journal of Immunology, 2020 - journals.aai.org
Abstract Coronavirus disease-2019 (COVID-19) is caused by the newly emerged virus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and was recently declared …
被引用次数：63 相关文章 所有 5 个版本